535
Views
44
CrossRef citations to date
0
Altmetric
Research Article

Sudden sensorineural hearing loss: A vascular cause? Analysis of prothrombotic risk factors in head and neck

, , , , , , , & show all
Pages 800-805 | Received 30 May 2012, Accepted 20 Jun 2012, Published online: 29 Aug 2012

References

  • Adams H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B. . 1993. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke, 24, 35–41.
  • Araki A. & Sako Y. 1987. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr, 422, 43–52.
  • Bejot Y., Catteau A., Caillier M., Rouaud O. & Durier J. 2008. Trends in incidence, risk factors, and survival in symptomatic lacunar stroke in Dijon, France, from 1989 to 2006: A population-based study. Stroke, 39, 1945–1951.
  • Bick R.L. 1997. Antiphospholipid thrombosis syndromes: Etiology, pathophysiology, diagnosis, and management. Int J Hematol, 65, 193–213.
  • Byl F.M. 1984. Sudden hearing loss: Eight years’ experience and suggested prognostic table. Laryngoscope, 94, 647–661.
  • Cadoni G., Scipione S., Agostino S., Addolorato G., Cianfrone F. . 2007. Coenzyme Q 10 and cardiovascular risk factors in idiopathic sudden sensorineural hearing loss patients. Otol Neurotol, 28, 878–883.
  • Cahill M.T., Stinnett S.S. & Fekrat S. 2003. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol, 136, 1136–1150.
  • Capaccio P., Ottaviani F., Cuccarini V., Ambrosetti U., Fagnani E. . 2005. Methylenetetrahydrofolate reductase gene mutations as risk factors for sudden hearing loss. Am J Otolaryngol, 26, 383–387.
  • Capaccio P., Ottaviani F., Cuccarini V., Bottero A., Shindler A. . 2007. Genetic and acquired prothrombotic risk factors and sudden hearing loss. Laryngoscope, 117, 547–551.
  • Choi B.O., Kim N.K., Kim S.H., Kang M.S. & Lee S. 2003. Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions. Thromb Res, 111, 39–44.
  • De Klein A. 1944. Sudden complete or partial loss of function of the octavus-system in apparently normal persons. Acta Otolaryngol (Stockh), 32, 407–429.
  • Den Heijer M., Lewington S. & Clarke R. 2005. Homocysteine, MTHFR and risk of venous thrombosis: A meta-analysis of published epidemiological studies. J Thromb Haemost, 3, 292–299.
  • Eldibany M.M. & Caprini J.A. 2007. Hyperhomocysteinemia and thrombosis: An overview. Arch Pathol Lab Med, 131, 872–884.
  • Fegan C.D. 2002. Central retinal vein occlusion and thrombophilia. Eye (Lond), 16, 98–106.
  • Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A. . 1995. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet, 10, 111–113.
  • Fujimaki C., Hayashi H., Tsuboi S., Matsuyama T., Kosuge K. . 2009. Plasma total homocysteine level and methylenetetrahydrofolate reductase 677C > T genetic polymorphism in Japanese patients with rheumatoid arthritis.Biomarkers, 14, 49–54.
  • Fusconi M., Chistolini A., Angelosanto N., Pignoloni P., Tombolini M. . 2011. Role of genetic and acquired prothrombotic risk factors in genesis of sudden sensorineural hearing loss. Audiol Neurootol, 16, 185–190.
  • Goodhill V. & Harris I. 1979. Sudden hearing loss syndromes. In: V. Goodhill (ed.), Ear Diseases, Deafness, and Dizziness. New York: Harper-Collins, pp. 664–681.
  • Hassan A., Hunt B.J., O’Sullivan M., Bell R. & D’Souza R. 2004. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain, 127, 212–219.
  • Hayreh S.S., Podhajsky P.A. & Zimmerman M.B. 2011. Natural history of visual outcome in central retinal vein occlusion. Ophthalmology, 118, 119–133.
  • Hayreh S.S., Zimmerman M.B., Kimura A. & Sanon A. 2004. Central retinal artery occlusion.Retinal survival time. Exp Eye Res, 78, 723–736.
  • Ho J.D., Tsai C.Y., Liou S.W., Tsai R.J. & Lin H.C. 2008. Seasonal variations in the occurrence of retinal vein occlusion: A five-year nationwide population-based study from Taiwan. Am J Ophthalmol, 145, 722–728.
  • Hotoleanu C., Porojan-Iuga M., Rusu M.L. & Andercou A. 2007. Hyperhomocysteinemia: Clinical and therapeutical involvement in venous thrombosis. Rom J Intern Med, 45, 159–164.
  • Janssen M.C., den Heijer M., Cruysberg J.R., Wollersheim H. & Bredie S.J. 2005. Retinal vein occlusion: A form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost, 93, 1021–1026.
  • Klein R., Moss S.E., Meuer S.M. & Klein B.E. 2008. The 15-year cumulative incidence of retinal vein occlusion: The Beaver Dam Eye Study. Arch Ophthalmol, 126, 513–518.
  • Lee E.J., Cho Y.J. & Yoon Y.J. 2010. Methylenetetrahydrofolate reductase C677T gene mutation as risk factor for sudden sensorineural hearing loss: Association with plasma homocysteine, folate, and cholesterol concentrations. J Laryngol Otol, 124, 1268–1273.
  • Mamak A., Yilmaz S., Cansiz H., Inci E., Guclu E. . 2005. A study of prognostic factors in sudden hearing loss. Ear Nose Throat J, 84, 641–644.
  • Marcucci R., Alessandrello Liotta A., Cellai A.P., Rogolino A., Berloco P. . 2005. Cardiovascular and thrombophilic risk factors for idiopathic sudden sensorineural hearing loss. J Thromb Haemost, 3, 929–934.
  • Marti-Carvajal A.J., Sola I., Lathyris D. & Salanti G. 2009. Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev, CD006612.
  • Mattox D.E. & Simmons F.B. 1977. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol, 86, 463–480.
  • McGimpsey S.J., Woodside J.V., Cardwell C., Cahill M. & Chakravarthy U. 2009. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: A meta-analysis. Ophthalmology, 116, 1778–1787.
  • Parnetti L., Caso V., Santucci A., Corea F., Lanari A. . 2004. Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke. Neurol Sci, 25, 13–17.
  • Prisco D. & Marcucci R. 2002. Retinal vein thrombosis: Risk factors, pathogenesis, and therapeutic approach. Pathophysiol Haemost Thromb, 32, 308–311.
  • Quinlivan E.P. & Gregory J.F. 2003. Effect of food fortification on folic acid intake in the United States. Am J Clin Nutr, 77, 221–225.
  • Rao R., Tah V., Casas J.P., Hingorani A., Whittaker J. . 2009. Ischaemic stroke subtypes and their genetic basis: A comprehensive meta-analysis of small and large vessel stroke. Eur Neurol, 61, 76–86.
  • Rudack C., Langer C., Stoll W., Rust S. & Walter M. 2006 .Vascular risk factors in sudden hearing loss. Thromb Haemost, 95, 454–461.
  • Sacco S., Marini C., Totaro R., Russo T., Cerone D. . 2006. A population-based study of the incidence and prognosis of lacunar stroke. Neurology, 66, 1335–1338.
  • Uchida Y., Sugiura S., Ando F., Shimokata H. & Nakashima T. 2010Association of the C677T polymorphism in the methylenetetrahydrofolate reductase gene with sudden sensorineural hearing loss. Laryngoscope, 120, 791–795.
  • Wilcken B., Bamforth F., Li Z., Zhu H., Ritvanen A. . 2003. Geographical and ethnic variation of the 677C > T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): Findings from over 7000 newborns from 16 areas worldwide. J Med Genet, 40, 619–625.
  • Yamada K., Chen Z., Rozen R. & Matthews R.G. 2001. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA, 98, 14853–14858.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.